Patents by Inventor Martin Pearse

Martin Pearse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230279129
    Abstract: The present disclosure relates to a method for preventing or treating ischemia-reperfusion injury in a subject the method comprising administering a compound that inhibits granulocyte colony stimulating factor (G-CSF) signaling. In some examples, the ischemia-reperfusion injury is due to or associated with tissue or organ transplantation. In some examples, the compound is an antibody.
    Type: Application
    Filed: January 10, 2023
    Publication date: September 7, 2023
    Applicant: CSL Limited
    Inventors: Ingela VIKSTROM, Adriana BAZ MORELLI, Martin PEARSE
  • Publication number: 20210179721
    Abstract: The present disclosure relates to a method for preventing or treating ischemia-reperfusion injury in a subject the method comprising administering a compound that inhibits granulocyte colony stimulating factor (G-CSF) signaling. In some examples, the ischemia-reperfusion injury is due to or associated with tissue or organ transplantation. In some examples, the compound is an antibody.
    Type: Application
    Filed: November 29, 2018
    Publication date: June 17, 2021
    Applicant: CSL Limited
    Inventors: Ingela VIKSTROM, Adriana BAZ MORELLI, Martin PEARSE
  • Patent number: 8999353
    Abstract: A method for eliciting or inducing a protective immune response in a subject against a pandemic subtype of influenza virus comprises administering to the subject a composition comprising (i) at least one immunogen of an endemic influenza subtype, and (ii) an immunogen-free immunostimulating complex as adjuvant.
    Type: Grant
    Filed: October 9, 2008
    Date of Patent: April 7, 2015
    Assignee: CSL Limited
    Inventors: Martin Pearse, Steve Rockman, David Ryan
  • Publication number: 20100291146
    Abstract: A method for eliciting or inducing a protective immune response in a subject against a pandemic subtype of influenza virus comprises administering to the subject a composition comprising (i) at least one immunogen of an endemic influenza subtype, and (ii) an immunogen-free immunostimulating complex as adjuvant.
    Type: Application
    Filed: October 9, 2008
    Publication date: November 18, 2010
    Applicant: CSL Limited
    Inventors: Martin Pearse, Steve Rockman, David Ryan